Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Wave Life Sciences Ltd. (NASDAQ: WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE ...

D-Wave Quantum’s stock has gone on a wild ride since its public debut. It’s locking in a lot of customers but barely generating any revenue from them. Its sky-high valuations could limit its near-term ...

Investors want to see the math add up and are questioning how much premium they're willing to pay for the promise of future returns. While D-Wave isn't an AI stock per se, it has become caught up in ...

Wave Life Sciences Ltd. remains a high-risk, high-reward biotech with a unique RNA-based pipeline targeting AATD, obesity, DMD, and Huntington's Disease. I maintain a speculative Buy rating, driven by ...

This concept isn’t new—in fact, it is the essence of representational state transfer (REST). Instead of converting to a ...

There’s a key factor limiting the power of a potential Democratic surge next year: the number of seats that are realistically competitive. Even as this year’s election results have left many in the ...